ConductScience.org, home

Library / Trials

The Impact of Peanuts on Brain Function in Young Adults

NCT07930325, Not applicable, Recruiting, William & Mary

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleThe Impact of Peanuts on Brain Function in Young AdultsClinicalTrials.gov
NCT numberNCT07930325ClinicalTrials.gov
StatusRecruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment100 participants, estimatedClinicalTrials.gov
Lead sponsorWilliam & MaryClinicalTrials.gov
ConditionsStressClinicalTrials.gov
InterventionsPeanuts, PretzelsClinicalTrials.gov
First posted2026-11-12ClinicalTrials.gov
Last updated2026-11-12ClinicalTrials.gov

Registered outcomes 19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryPrefrontal Cortex RecruitmentBaseline and 8 WeeksFunctional Near Infrared Spectroscopy Oxygenated Hemoglobin Concentrations During Cognitive Tasks Across the Prefrontal Cortex (HbO) (mm\*mM).ClinicalTrials.gov
PrimarySleep ArchitectureNightly for 8 weeksDuration sleep (minutes), duration in light sleep (minutes), duration in REM sleep (minutes), duration in deep sleep (minutes), awakening during the night, and sleep efficiency.ClinicalTrials.gov
PrimaryPerceived StressDaily for 8 weeksEcological Momentary Assessments on a Scale of 1-100. 1 = no stress and 100 = extremely high stress.ClinicalTrials.gov
PrimaryCognitive Performance During the Digit Span TaskBaseline and Week 8Error Made (#) on Digit Span TaskClinicalTrials.gov
PrimaryPerceived FatigueDaily for 8 weeksEcological Momentary Assessments (Scale of 1-100). 1 = no fatigue and 100 = extremely high fatigue.ClinicalTrials.gov
PrimaryPerceived StressBaseline, Week 4, and Week 8Perceived Stress Questionnaire (the final tabulated score ranges from 0 -1 with 1 indicating higher perceived stress).ClinicalTrials.gov
PrimaryAcute stress responses 1Baseline and Week 8Salivary alpha-amylase (U/mL) in response to the Montreal Imaging Stress TaskClinicalTrials.gov
PrimaryAcute stress responses 2Baseline and 8 WeeksSalivary cortisol (ug/dL) in response to the Montreal Imaging Stress TaskClinicalTrials.gov
PrimaryHeart rate variabilityDaily for 8 weeksDaily heart rate variability (milliseconds)ClinicalTrials.gov
PrimaryCognitive Performance During the Spatial Recall TaskBaseline and Week 8Immediate and Delayed Recall Accuracy (%) and Duration (Seconds)ClinicalTrials.gov
PrimaryCognitive Performance During the Symbol Digit Substitution TaskBaseline and Week 8Percent Accuracy (%)ClinicalTrials.gov
PrimaryCognitive Performance During the Trail Making TaskBaseline and Week 8Number of Errors (#) and Duration (seconds)ClinicalTrials.gov
PrimaryFatigue and SleepinessBaseline, Week 4, and Week 8Epworth Sleepiness Scale Score: 0-10 Normal range in healthy adults 11-14 Mild sleepiness 15-17 Moderate sleepiness 18 or higher Severe sleepinessClinicalTrials.gov
PrimaryMental HealthBaseline, Week 4, and Week 8
Depression, Anxiety, Stress Scale-21 Score Interpretation: Depression \| Anxiety \| Stress Normal 0-9 \| 0-7\| 0-14 Mild 10-13 \| 8-9 \| 15-18 Moderate 14-20 \| 10-14 \| 19-25 Severe 21-27 \| 15-19 \| 26-33 Extremely Severe 28+ \| 20+ \| 34+
ClinicalTrials.gov
PrimaryPerceived Sleep QualityTOTAL < 5 associated with good sleep quality TOTAL > 5 associated with poor sleep qualityPittsburgh Sleep Quality IndexClinicalTrials.gov
SecondaryBody WeightBaseline and Week 8Body Weight (pounds)ClinicalTrials.gov
SecondaryWaist CircumferenceBaseline and Week 8InchesClinicalTrials.gov
SecondaryBlood PressureBaseline and Week 8Systolic and Diastolic Blood Pressure (mmHg)ClinicalTrials.gov
SecondaryNutrient IntakeBaseline, Week 4, Week 824 hour dietary recallClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Digit Span TestPrimary outcomeConductCognition
Trail Making Test APrimary outcomeConductCognition
Trail Making Test BPrimary outcomeConductCognition

Source 4

FieldValueSource
Releasetrials-2026-11-12-0.3.0ClinicalTrials.gov
Release manifest SHA-2564a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.3.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.